GI Cancers
Colorectal Cancer Alliance Issues Letter in Support of USPSTF
The CCA recently issued a letter to Secretary Robert F. Kennedy Jr. urging him to preserve the independence of the USPSTF and maintain no-cost access to colorectal cancer screening starting at age 45.
SEPTEMBER 1, 2025
‘Right-Sizing’ Surveillance Intervals for CRC: Considerations for Now and the Future
The 2020 guidelines for surveillance colonoscopy have steered clinicians toward more appropriate surveillance intervals, but research continues to refine individual risk and recommendations, according to the guideline author, Samir Gupta, MD.
AUGUST 25, 2025
Inflammatory Diet Associated With Worse Survival in Patients With Stage III Colon Cancer
Results from a large prospective cohort study reveal that eating a less inflammatory diet may improve survival for patients with stage III colon cancer.
AUGUST 20, 2025
Early Detection of Pancreatic Cancer With Biomarkers Becoming a Reality
The early detection of pancreatic ductal adenocarcinoma may soon be realized, based on the accuracy of microRNA-based liquid biopsy assays, according to new research.
AUGUST 15, 2025
Robotic Surgery Improves 3-Year Relapse-Free Survival in Rectal Cancer
A real-world study has concluded that robotic surgery significantly improves three-year relapse-free survival compared with laparoscopic surgery in rectal cancer patients.
AUGUST 11, 2025
Circulating Tumor DNA Blood Test Shows Promise for Colorectal Cancer Screening
A circulating tumor DNA–based blood test demonstrated its ability to accurately detect colorectal cancer among a population of average-risk individuals.
AUGUST 6, 2025
More Data on Role of Statins in Prevention of HCC and Chronic Liver Disease
A new large retrospective study lends further credence to the evolving theory that statins may help prevent hepatocellular carcinoma and chronic liver disease progression.
JULY 28, 2025
Mixed Results Seen for PREEMPT CRC Screening Test
The PREEMPT CRC study met its primary end points but with a lower magnitude of benefit than investigators had hoped.
JULY 16, 2025
Study Links Severity of Obesity to Elevated Risk for BE and Esophageal Cancer
The risk of developing BE and EAC increases with severity of obesity, according to a new study presented at DDW 2025.
JULY 14, 2025
FDA Approves SIR-Spheres for Unresectable HCC
The FDA approved yttrium-90 (Y-90) resin microspheres (SIR-Spheres, Sirtex Medical) for the treatment of unresectable hepatocellular carcinoma (HCC).
JULY 11, 2025
New Regimen for Localized Gastric Cancers Presented at ASCO
Adding the immunotherapy Imfinzi to standard chemotherapy improves outcomes for people with resectable gastric or gastroesophageal junction cancer, per results presented at the 2025 ASCO Annual Meeting.
JUNE 18, 2025
Coordinated CRC Screening Outreach Found Effective in 2 Studies
Two new studies support the use of mailed fecal immunochemical colorectal cancer screening kits with follow-up to improve CRC screening.
JUNE 4, 2025
